Dr. Yan Chen
My Social Links

Dr. Yan Chen

Director and Professor
Department of Pediatrics, Affiliated Hospital of Zunyi Medical University, China


Highest Degree
Ph.D. in Medicine from Sichuan University, China

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Hematological Malignancy
62%
Pediatrics
90%
Hematological Malignancy
75%
Lymphoma and Leukemia
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
75
Abstracts
0

Selected Publications

  1. Xu, Y., J. Li, Y. Luo, J. Ma, P. Huang, Y. Chen and Z. He, 2023. Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and >i via inhibiting β-ARs signaling pathway. Biochem. Biophys. Res. Commun., 639: 150-160.
    CrossRef  |  Direct Link  |  
  2. Wang, J., P. Huang, C. Lang, Y. Luo, Z. He and Y. Chen, 2023. The progress in the relationship between trace elements and acute lymphoblastic leukemia. Front. Cell Dev. Biol., Vol. 11. 10.3389/fcell.2023.1145563.
    CrossRef  |  Direct Link  |  
  3. Luo, Y., Y. Xu, X. Li, X. Shi, P. Huang, Y. Chen and Z. He, 2022. A prognostic model of seven immune genes to predict overall survival in childhood acute myeloid leukemia. BioMed Res. Int., Vol. 2022. 10.1155/2022/7724220.
    CrossRef  |  Direct Link  |  
  4. Huang, P., C. Huang, H. Xu, J. Lu, R. Tian, Z. Wang and Y. Chen, 2020. Early use of blood purification in severe epstein-barr virus-associated hemophagocytic syndrome. Pediatrics, Vol. 145. 10.1542/peds.2019-3197.
    CrossRef  |  Direct Link  |  
  5. Tan, M., Y. Rong, Q. Su and Y. Chen, 2017. Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells. Leukemia Res., 62: 98-103.
    CrossRef  |  Direct Link  |